Silent artery disease exposed: 16,000-Person study aims to predict heart attacks before they happen

NCT ID NCT06692127

First seen Jul 13, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study scans over 16,000 adults aged 18 to 70 without known heart disease to find hidden (silent) plaque in their arteries using ultrasound and CT scans. The goal is to measure how common silent atherosclerosis is and build a risk calculator that combines imaging, lifestyle, and biomarkers to predict who will develop heart disease. Ultimately, this knowledge could lead to earlier, more personalized prevention strategies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a simple screening tool that identifies people with hidden artery disease years before a heart attack or stroke, enabling early prevention.
What could go wrong
This is an observational study, not a treatment trial. The risk calculator will need further testing before it can be used in routine care, and it may not work equally well for all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATHEROSCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC)

    Madrid, E-28029, Spain

  • Herlev Hospital

    Herlev, 2730, Denmark

  • Regionshospitalet Gødstrup

    Herning, 7400, Denmark

  • Righospitalet - Glostrup Hospital

    Glostrup Municipality, 2600, Denmark

  • Rigshospitalet

    Copenhagen, 2100, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.